Latest Drug Discovery News

The Menz Club, LLC . Issues a voluntary nationwide recall of V-Maxx Rx due to undeclared sulfoaildenafilAn FDA lab analysis of V Maxx Rx Lot # 101109 distributed by The Menz Club, LLC was found to contain undeclared sulfoaidenafil. Sulfoaidenafil is an analog of sildenafil, an FDA approved prescription drug used to treat Erectile Dysfunction (ED), maki...

Safe to Switch Thiopurines in IBD Patients (CME/CE)SAN DIEGO (MedPage Today) -- A majority of patients with inflammatory bowel disease who are unable to tolerate azathioprine may be able to take the related drug mercaptopurine safely, a researcher said here.

Sanofi's cholesterol drug reports positive test resultsPARIS (Reuters) - An experimental cholesterol treatment being jointly developed by Regeneron and Sanofi has shown it can lower bad cholesterol levels in difficult-to-treat patients, according to data from a mid-stage study published on Saturday.

Sanofi to Start China Clinical Trial of Cancer Drug In-licensed from SIBSSanofi hopes to begin a Phase I clinical trial in China next year of a novel drug that targets liver cancer. The molecule inhibits the slit-robo signaling path that controls tumor vasculature and tumor growth, a discovery made by researchers at th...

Game Is Designed to Help Doctors to Spot Drug AbuseA new video game draws on technology used to train F.B.I. agents and is meant to help doctors look for warning signs of patients likely to abuse prescription painkillers.

Miralax, a Drug for Adults, Is Popular as a Children’s RemedyMiralax has become a long-term solution for childhood constipation.

Bayer seeks US FDA approval for regorafenib to treat metastatic colorectal cancerBayer HealthCare,, the US─based pharmaceuticals business of Bayer HealthCare LLC, a subsidiary of Bayer AG, has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval for the oral multi─kinase inhibit...

Better blood pressure control with antihypertensive drug comboNEW YORK (Reuters Health) - Among elderly hypertensive patients in Japan, adding a calcium channel blocker (CCB) to an angiotensin II receptor blocker (ARB) provided better blood pressure control than a doubled dose of the ARB.

"Stem Cells Market Will Reach $7.3 Billion in 2014," Visiongain Report PredictsLondon, United Kingdom, May 26, 2012 --(PR.com)-- That market will be stimulated by new treatments and increasing use of related products in drug development. Those findings appear in Stem Cell Technologies: World Market Outlook 2012-2022, published in May 2012. Visiongain is a business information provider based in London, UK. Visiongain forecasts that the stem cells market will expand rapidly...

Orphan Sleep Drug Findings May Lead To New Cancer TherapiesA new study published in the Proceedings of the National Academy of Sciences reveals that an inexpensive "orphan drug" for the treatment of sleep disorders seems to be a potent inhibitor of cancer cells...

Luddite Greens repeatedly and viscerally anti-science - Take the Flour Back is the latest incarnationAdam Rutherford in the comments at Comment is free does a better job than Sunny Hundal, so let's accept Sense About Science's Tweeted suggestion and promote him to top billing:Dear Sunny,Some interesting points, and a considered pov, as usual. A couple of things worth noting. I'm interested in the longview of opposition to biotechnology that is based on recombinant DNA. Since its discovery/inventi...

Rite Aid Names John T. Standley Board ChairmanRite Aid Corporation (NYSE:RAD) announced that its Board of Directors has elected John T. Standley, who is currently President, Chief Executive Officer and a member of the Company’s Board of Directors, to the additional position of Chairman of the Board, effective June 21, 2012 at the Company’s annual stockholder meeting. Standley will succeed...

The drug industry is a barrier to diabetes care in poor countriesIn many parts of the world, people with type 1 diabetes (whether or not the condition is diagnosed) still die for want of insulin, and those with type 2 diabetes go without treatments that prolong...

Deals Of The Week Jump Starts The Summer Reading List

High on the New York Times List of Bestsellers (in the hardcover advice & miscellaneous category) this spring has been the book “Innovation: Create Far From Home, Win Everywhere.”It’s by two well-known Dartmouth business school professors,...

Clinilabs Opens Phase I Unit in New JerseyClinilabs, an early phase and specialty CRO that provides clinical drug development services to the pharmaceutical industry, announced Thursday that they have opened a second Phase I unit in Southern New Jersey.

Senator seeks to extend therapeutic tax creditSen. Robert Menendez (D-N.J.) introduced a bill that would extend the therapeutic discovery project program (TDPP) by an additional $1 billion in 2012. The program, which originally provided $1 billion through the end of 2010, was designed to provide...

CHMP: Pradaxa benefits outweigh bleeding riskEMA's CHMP completed a review of the risk of bleeding associated with Pradaxa dabigatran from Boehringer Ingelheim GmbH (Ingelheim, Germany) and recommended updating the label of the atrial fibrillation (AF) drug to include clearer guidance on how to...

House to vote on PDUFA bill next weekThe U.S. House of Representatives will vote on its version of PDUFA reauthorization legislation next Wednesday, according to a memo sent to House Republicans by Majority Leader Eric Cantor (R-Va.). Cantor hopes to reach an agreement with the Senate b...

Short Course of Drug Fails in Vent-Associated Pneumonia (CME/CE)SAN FRANCISCO (MedPage Today) -- A short course of high-dose doripenem (Doribax) for ventilator-associated pneumonia did more harm than good, and a clinical trial testing the approach was stopped early, a researcher said here.

Tranzyme GI drug fails second late-stage trial(Reuters) - Tranzyme Pharma said its experimental drug to improve gastrointestinal recovery after surgery failed to meet the main or secondary goals of a second late-stage trial.

Vertex's Cystic Fibrosis Drug Kalydeco Given Green Light By EU's Scientific Advisory PanelVertex's cystic fibrosis product Kalydeco is one of five new molecular entities given a positive opinion by Europe's Committee for Medicinal Products for Human Use on May 25, which also included Almirall's novel COPD therapy aclidinium and Novo Nordi...

Pacific Quest Announces New Clinician HiresPacific Quest Wilderness Therapy, an outdoor therapeutic program for struggling adolescents and young adults, announces the hiring of two new primary clinicians, Haley Robinson and Bridger Jensen Hilo, HI (PRWEB) May 25, 2012 Pacific Quest Wilderness Therapy is pleased to announce the addition of two new clinicians to our Ohana! Haley Robinson and Bridger Jensen will both be joining Pacific Quest...

Arizona may add more uses for medical marijuanaArizona is considering requests to expand its fledgling medical marijuana program to allow use of the drug for an array of conditions, including post-traumatic stress syndrome and migraines, beyond those allowed under the law approved by voters two...

Advanced Biological Laboratories' DeepChek® and ViroScore® Suite Clinical Genotyping Solutions For Personalized Treatment of HIV Receive CE Mark for In Vitro Diagnostic UseAdvanced Biological Laboratories (ABL) announced today that DeepChek® and ViroScore® Suite clinical genotyping solutions are now CE-IVD (In Vitro Diagnostics) approved for commercial use in Europe and other countries that recognise CE certification. This approval is further validating the use of our next generation sequencing (NGS) downstream an...

FDA clears Medigus SRS endoscopic systemThe US Food and Drug Administration (FDA) has granted 510(k) approval to Medigus's SRS endoscopic system.

0 1 2 3 4 ›»

buy Drug Discovery market research data and corporate reports now Advertisement